10:09 AM EST - Appili Therapeutics Inc. : Has delivered formal notice to Aditxt to terminate the arrangement agreement dated April 1, 2024 (as amended) between the Company, Aditxt and its wholly-owned subsidiary, Adivir, Inc. Such termination is effective as of May 30, 2025. Appili Therapeutics Inc.
shares T.APLI are trading unchanged at $0.02.
